Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-14 · accession 0001411690-25-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-18 | 2025-03-14 | BNGO | Holmlin R. Erik | Pres, CEO, Dir | F - Tax | $3.47 | -198 | 1,783 | -10% | -$687.06 |
| D | 2025-03-18 | 2025-03-14 | BNGO | Holmlin R. Erik | Pres, CEO, Dir | A - Grant | $0.00 | +17.4K | 17.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-14 | F | D | 198 | $3.47 | 1,783 | D | — | — | (F1) The reporting person is reporting the withholding by the Issuer of an aggregate of 198 shares of common stock in connection with shares that vested on March 14, 2025 pursuant to an PSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the PSU award. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-03-14 | A | A | 17,449 | $0.00 | 17,449 | D | $3.47 · — to 2035-03-13 | 17,449 Common Stock | (F2) Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. |